VIPhyb (compound VIPhyb) is a vasoactive intestinal polypeptide (VIP) receptor antagonist that can be used in the study of cancers such as non-small cell lung cancer (NSCLC)[1].
Molecular Weight:
3467.06
Purity:
99.73
CAS Number:
[125093-93-8]
Formula:
C154H257N49O40S
Target:
Biochemical Assay Reagents
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted